First-day step-down to oral outpatient treatment versus continued standard treatment in children with cancer and low-risk fever in neutropenia. A randomized controlled trial within the multicenter SPOG 2003 FN study-Reference-Cited by-同舟云学术

First-day step-down to oral outpatient treatment versus continued standard treatment in children with cancer and low-risk fever in neutropenia. A randomized controlled trial within the multicenter SPOG 2003 FN study

Published:2012-01-23 Issue:3 Volume:59 Page:423-430
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr. Blood Cancer

Author:

Brack Eva,Bodmer Nicole,Simon Arne,Leibundgut Kurt,Kühne Thomas,Niggli Felix K.,Ammann Roland A.

Funder

Oncosuisse/Swiss Cancer League

Bayer AG

GSK AG

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.24076/fullpdf

Reference43 articles.

1. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia;Bodey;Ann Intern Med,1966

2. Risk assessment in cancer patients with fever and neutropenia: A prospective, two-center validation of a prediction rule;Talcott;J Clin Oncol,1992

3. The multinational association for supportive care in cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients;Klastersky;J Clin Oncol,2000

4. Management of febrile neutropenia: ESMO clinical practice guidelines;de Naurois;Ann Oncol,2010

5. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America;Freifeld;Clin Infect Dis,2011

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostics and therapy of paediatric patients with febrile neutropenia;EJC Paediatric Oncology;2023-12

2. Safety of Procalcitonin Guided Early Discontinuation of Antibiotic Therapy among Children Receiving Cancer Chemotherapy and Having Low-Risk Febrile Neutropenia: A Randomized Feasibility Trial (ProFenC Study);Pediatric Hematology and Oncology;2023-09-01

3. Outcome prediction in pediatric fever in neutropenia: Development of clinical decision rules and external validation of published rules based on data from the prospective multicenter SPOG 2015 FN definition study;PLOS ONE;2023-08-02

4. Clinical Characteristics and Management of Febrile Neutropenia among Pediatric Cancer Patients Admitted at Tertiary Hospital in Dar es Salaam;SN Comprehensive Clinical Medicine;2022-06-13

5. Safety of reducing antibiotic use in children with febrile neutropenia: A systematic review;Pediatric Hematology and Oncology;2022-04-23